MVST · Microvast Holdings, Inc.

Microvast’s Q1 2026 results reflect a sharp contraction in top-line revenue—down 48.0% year-over-year to $60.6 million—driven by delivery timing shifts, regulatory and geopolitical disruptions in India and Korea, demand migration toward lower-cost products in India, and OEM platform ramp-up delays. Revenue by region shows steep declines across all geographies: APAC fell 66%, Europe 28%, and the USA 96%, underscoring broad-based execution challenges rather than isolated market weakness. Gross margin declined to 31.6% from 36.9% YoY, attributed explicitly to lower production utilization reducing fixed cost absorption—a structural concern given Microvast’s capital-intensive manufacturing model. While GAAP net profit remained positive at $48.2 million, this included a $63.8 million non-cash gain from changes in fair value of warrants and convertible loan; stripping out such items, non-GAAP adjusted net loss was $14.6 million—versus $19.3 million profit in Q1 2025—and non-GAAP adjusted EBITDA swung to negative $5.5 million from positive $28.5 million, confirming deteriorating core operating performance. Management attributes the shortfall to transitory factors—including delayed customer demand alignment—and points to Huzhou Phase 3.2 serial production and Clarksville localization as pivotal 2026 catalysts. However, the magnitude of the revenue and margin decline, coupled with negative adjusted EBITDA and widening non-GAAP losses, raises questions about the timeline and credibility of the path to consistent profitability. The $4.8 million sequential increase in cash to $174.0 million provides near-term liquidity, but sustained negative adjusted EBITDA implies continued cash burn absent meaningful operational improvement or external financing.